Sep 23, 2026 9 0
Uploaded by Kurz
Favorite
Share
More Options
15
Antineoplastic agent-associated interstitial lung disease in breast, ovarian, and prostate cancers - a pharmacovigilance study using the FDA adverse event reporting system_Page 1

Open in WPS to view all 15 pages